Compliance Rate

Compliance Rate 0.0%
Compliant submissions 0
Incompliant submissions 1
Total trials 1

My Organizations' Clinical Trials

Showing 250 of 1322 entries
View as:

Improving Consent and Survey Procedures for Young MSM in Web-based HIV Prevention

Phase: N/A Priority: Normal
NCT ID: NCT02139566 Org: User:
Start: 07/31/14 End: 09/30/15 Due: 09/30/16

Linking Individuals Needing Care for Substance Use Disorders to Peer Coaches

Phase: N/A Priority: Normal
NCT ID: NCT05847621 Org: User:
Start: 08/16/24 End: 10/31/25 Due: 10/31/26

NMDA Receptors in Motor Learning in Humans

Phase: N/A Priority: Normal
NCT ID: NCT02082912 Org: User:
Start: 06/30/10 End: 04/30/12 Due: 04/30/13

Phase I Trial of Stereotactic Radiosurgery Following Surgical Resection of Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT01395407 Org: User:
Start: 07/31/11 End: 10/31/15 Due: 10/31/16

Targeting Reconsolidation to Prevent Return of Fear

Phase: N/A Priority: Normal
NCT ID: NCT01623830 Org: User:
Start: 07/31/12 End: 06/30/16 Due: 06/30/17

Comparison of Gabapentin and Pregabalin for Radicular Pain

Phase: N/A Priority: Normal
NCT ID: NCT02064790 Org: User:
Start: 04/30/14 End: 12/31/15 Due: 12/31/16

Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)

Phase: N/A Priority: Normal
NCT ID: NCT01426256 Org: User:
Start: 10/31/11 End: 07/31/17 Due: 07/31/18

HORIZONS HIV Intervention

Phase: N/A Priority: Normal
NCT ID: NCT00633906 Org: User:
Start: 04/30/02 End: 10/31/05 Due: 10/31/06

Mindfulness in Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT04099992 Org: User:
Start: 09/20/19 End: 08/31/25 Due: 08/31/26

Tumor Treating Fields for the Treatment of Brainstem Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT05310448 Org: User:
Start: 05/11/22 End: 05/01/26 Due: 05/01/27

Characterization Of the Intestinal Microbiome Evolution After Kidney Transplant Donation or Receipt

Phase: N/A Priority: Normal
NCT ID: NCT03043339 Org: User:
Start: 10/02/17 End: 01/10/19 Due: 01/10/20

Etanercept and Vascular Function in Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01989689 Org: User:
Start: 08/31/10 End: 09/30/13 Due: 09/30/14

Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02701400 Org: User:
Start: 04/14/16 End: 08/07/20 Due: 08/07/21

Dynamics of Inflammation and Its Blockade on Motivational Circuitry in Depression

Phase: N/A Priority: Normal
NCT ID: NCT03006393 Org: User:
Start: 08/31/16 End: 09/26/20 Due: 09/26/21

Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT

Phase: N/A Priority: Normal
NCT ID: NCT02575079 Org: User:
Start: 03/31/15 End: 03/29/18 Due: 03/29/19

Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02273752 Org: User:
Start: 11/30/14 End: 12/31/15 Due: 12/31/16

Magnetic Resonance Spectroscopy (MRS) in Midlife Depression

Phase: N/A Priority: Normal
NCT ID: NCT02567110 Org: User:
Start: 07/31/16 End: 02/04/22 Due: 02/04/23

Insulin Delivery Using Microneedles in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00837512 Org: User:
Start: 09/30/08 End: 07/31/13 Due: 07/31/14

Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01490749 Org: User:
Start: 02/29/12 End: 02/28/19 Due: 02/28/20

Dexamethasone Plus Virtual Reality Exposure Therapy for PTSD

Phase: N/A Priority: Normal
NCT ID: NCT01965366 Org: User:
Start: 10/31/13 End: 06/30/17 Due: 06/30/18

Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01446458 Org: User:
Start: 11/30/11 End: 03/31/15 Due: 03/31/16

Phase II Study of Everolimus Beyond Progression

Phase: N/A Priority: Normal
NCT ID: NCT02269670 Org: User:
Start: 11/25/14 End: 01/25/21 Due: 01/25/22

The ISLAND Study: InSuLa Assessed Needs for Depression

Phase: N/A Priority: Normal
NCT ID: NCT02137369 Org: User:
Start: 09/30/14 End: 10/24/19 Due: 10/24/20

Immune Response to Vaccination in Patients Receiving Single Drug Immunosuppression

Phase: N/A Priority: Normal
NCT ID: NCT01733056 Org: User:
Start: 01/31/11 End: 01/31/13 Due: 01/31/14

Enoxaparin Dosing in Obesity

Phase: N/A Priority: Normal
NCT ID: NCT01798550 Org: User:
Start: 03/31/13 End: 10/15/16 Due: 10/15/17